FOLR1 & FOLH, also known as FOLR & PSMA. FOLR1 is a protein that belongs to a member of the folate receptor family. FOLR1 binds to folic acid and its derivatives, which becomes crucial during fetal development. FOLR1, due to its high expression in some tumors, is an attractive therapeutic target for the development of novel anti-cancer agents in order to limit toxic side effects on off-target tissues. FOLH is a type II transmembrane glycoprotein belonging to the M28 peptidase family, a glutamate-preferring carboxy-peptidase. PSMA is highly expressed in prostate secretory-acinar epithelium, in some benign extraprostatic epithelial cells from breast, duodenum, and kidney tissues, and prostate cancer. In the prostate, the protein is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer.